Is Colloidal Gold Toxic? What the Science Says

Colloidal gold, at the doses found in most dietary supplements, does not appear acutely toxic to humans based on available evidence, but the picture is far from simple or fully reassuring. Animal studies consistently show that gold nanoparticles administered alone at low concentrations do not cause obvious organ damage or weight loss, yet higher concentrations and smaller particle sizes introduce a range of biological effects that researchers are still working to characterize. The safety of colloidal gold depends on a tangle of variables: how big the particles are, what coats their surface, how much you ingest, and what else is happening in your body at the time. That complexity is why scientists still debate the question and why “the science says” is less a verdict than an evolving conversation.

Why Particle Size Changes Everything

If there is one theme that runs through virtually every gold nanoparticle toxicity study, it is that size matters enormously. Gold nanoparticles in the range of roughly 25 to 50 nanometers tend to be taken up by cells in the highest numbers, while particles above 50 nm are internalized less efficiently because they demand more energy and more cellular receptors to be wrapped and pulled inside the cell.¹ But higher cellular uptake does not automatically translate to more gold inside each cell. Smaller particles enter in greater numbers, yet the total mass of gold delivered per cell can actually be much lower than with larger particles, because each tiny particle carries so little material.

When it comes to toxicity measured in cell cultures, though, the relationship gets more complicated. In breast cancer cell lines, for instance, 13 nm gold nanoparticles were found to be less toxic than 50 nm or 70 nm particles, with the smaller particles requiring a higher concentration to kill half the cells.² Meanwhile, at the level of the whole animal, the very smallest nanoparticles (under about 2 nm) behave almost like dissolved molecules, spreading throughout the body in ways that larger particles simply cannot. After oral administration to rats, 1.4 nm gold nanoparticles showed the highest accumulation in secondary organs compared to particles ranging up to 200 nm.³ This wide distribution is a double-edged sword: it is exactly what makes ultrasmall gold nanoparticles promising for drug delivery, and exactly what makes them harder to declare safe for casual consumption.

Where Gold Ends Up in the Body

When gold nanoparticles enter the bloodstream, whether injected or absorbed through the gut, the liver and spleen act as the primary collection points. After intravenous injection in rats, gold accumulated rapidly in both organs and stayed there for at least two months. Interestingly, kidney accumulation increased over time, appearing about a month after injection, while gold that initially showed up in the lungs cleared within a week. No gold was found in the brain in that particular study.⁴

Size again plays a decisive role in distribution. When researchers injected rats with gold nanoparticles of three different sizes (10, 50, 100, and 250 nm), the 10 nm particles spread to the widest range of organs, showing up in the blood, liver, spleen, kidney, testis, thymus, heart, lungs, and brain. Larger particles stayed mostly confined to the blood, liver, and spleen.⁵ This has practical implications for anyone thinking about colloidal gold supplements: the particles’ diameter shapes not just whether they are absorbed but where in the body they end up.

Oral intake, the route relevant to supplements, follows a different absorption pathway. Gold nanoparticles cross the gut wall by slipping through gaps left by dying intestinal cells at the tips of tiny finger-like projections called villi.⁶ As particle diameter decreases from 100 nm down to 15 nm, the rate of absorption by intestinal cells increases.⁷ But a biokinetic study in rats found that gold nanoparticles taken orally entered the bloodstream slowly and accumulated mainly in the kidneys, in contrast to ionic gold (dissolved gold salts), which was rapidly absorbed and distributed to the kidneys, liver, lungs, and spleen at much higher levels.⁸ That finding matters because it suggests the nanoparticulate form of gold behaves quite differently in the body than dissolved gold compounds do.

Getting It Back Out Again

One of the less reassuring aspects of gold nanoparticle research is how slowly the body clears them. After intravenous injection, only about 3 to 14 percent of the injected gold appeared in feces and urine within 12 hours.⁹ The rest lingers, predominantly in the liver and spleen. Clearance efficiency depends heavily on what coats the particle’s surface. In one comparison, gold nanoclusters protected by a small molecule called glutathione achieved about 36 percent renal clearance within 24 hours, and roughly 94 percent of the gold was eventually metabolized over 28 days. By contrast, gold nanoclusters protected by a larger protein (bovine serum albumin) managed only about 1 percent renal clearance in 24 hours, and less than 5 percent was metabolized after 28 days.¹⁰

This is relevant to the supplement question because most colloidal gold products do not specify their surface chemistry in any clinically meaningful way. The ease with which your body can flush out the gold particles you swallow depends on characteristics that supplement labels do not typically disclose.

Low Doses Alone Look Safe, but Combinations Are a Different Story

The most reassuring data for people curious about colloidal gold comes from studies where nanoparticles were given by themselves. In a mouse study, gold nanoparticles of 10, 50, and 100 nm administered alone produced no liver or kidney damage, with blood markers for organ injury staying at control levels.¹¹ In a separate study, 5 nm gold nanoparticles produced temporary liver changes in mice that diminished over about a week, with minimal effects on the kidneys regardless of particle size.¹²

However, a study testing multiple routes of administration in mice found that at high concentrations, gold nanoparticles caused drops in body weight, red blood cell counts, and other blood markers. Oral and intraperitoneal routes showed the highest toxicity compared to intravenous injection.¹³ That the oral route was among the most toxic is worth flagging, given that swallowing is the route supplement users take.

Perhaps more concerning than gold nanoparticles alone is what happens when they meet other substances in the body. In the same mouse study that found gold nanoparticles safe on their own, co-administering those particles with common drugs including cisplatin (a chemotherapy agent), mesalamine (used for inflammatory bowel disease), and paraquat (a herbicide) caused liver and kidney damage. The smallest particles, 10 nm, combined with these drugs produced the most severe injury, including acute kidney damage visible under the microscope. Particles of 100 nm did not produce this effect when paired with the same drugs.¹¹ The implication is uncomfortable: gold nanoparticles that seem inert by themselves may amplify the toxicity of drugs you happen to be taking.

What Happens at the Cellular Level

Even when gold nanoparticles do not cause visible organ damage, they are not biologically invisible once inside cells. In human lung fibroblasts, gold nanoparticles triggered autophagy, the process by which cells break down and recycle their own components. The same cells showed increased oxidative damage, with measurable rises in fat-derived molecules that signal the cell membranes are being attacked by reactive oxygen species.¹⁴ In cancer research, this oxidative stress is actually being exploited as a feature: gold nanoparticles can boost the reactive oxygen species produced by radiation therapy in cancer cells, potentially making radiation more effective at killing tumors.¹⁵ What helps kill cancer cells, though, is not necessarily something you want happening in your healthy tissues.

DNA damage is another area where the data gives pause. In rats given gold nanoparticles of 10 and 30 nm, both short-term and long-term administration caused DNA damage in the brain’s outer layer (the cerebral cortex), measured as increased frequency and severity of DNA strand breaks.¹⁶ In fish, all tested concentrations of gold, whether nanoparticle or ionic, induced DNA breaks and chromosome-level damage in red blood cells.¹⁷ DNA damage does not automatically translate into cancer or disease, since cells have repair machinery that deals with low-level breaks constantly. But repeated exposure to an agent that induces such damage is something toxicologists take seriously.

Nanoparticle Gold versus Ionic Gold

A persistent question in the research is whether gold nanoparticles are more or less dangerous than ionic gold, the dissolved form that has been used medically for decades in treatments for rheumatoid arthritis. The broad answer from multiple studies is that ionic gold tends to be more acutely toxic than the nanoparticulate form. In aquatic toxicity testing, the hazardous concentration threshold for nanoparticulate gold was about 43 mg/L, compared to roughly 2.4 mg/L for ionic gold, a difference of nearly 18-fold.¹⁸ In fish exposed to both forms, ionic gold caused actual mortality at the highest tested concentration while no fish died from nanoparticle exposure. Ionic gold also accumulated more heavily in fish tissues, likely explaining its greater effect.¹⁷

However, lower acute lethality does not mean harmless. The nanoparticulate form can still trigger oxidative stress and lipid damage, even at the lowest concentrations tested. And one freshwater bivalve study found that gold nanoparticles were actually taken up at rates about 10 times higher from water and 30 times higher from food compared to ionic gold, with stronger gene activation related to oxidative stress, immune response, and cell death.¹⁹ So the comparison is not a clean win for nanoparticles; it depends on the organism, the exposure route, and what biological endpoint you measure.

The Brain and the Blood-Brain Barrier

One of the more intriguing findings is that certain gold nanoparticles can cross the blood-brain barrier, the tightly regulated boundary that normally keeps most substances out of brain tissue. In a laboratory model using a six-cell brain spheroid, ultrasmall (2 nm) gold nanoparticles crossed the barrier without reducing cell viability, meaning they got in without immediately killing anything.²⁰ Glucose-coated 4 nm gold nanoparticles crossed human brain endothelium in culture at a rate at least three times faster than non-brain endothelial cells, eventually localizing in brain support cells (astrocytes) and even appearing in their nuclei in considerable numbers.²¹

This is being studied mostly as a therapeutic opportunity. TAT-peptide-modified gold nanoparticles of 5 nm showed roughly a five-fold increase in brain accumulation compared to unmodified particles in mice, making them candidates for delivering chemotherapy to brain tumors.²² But it also raises the question of what happens when gold particles casually consumed in a supplement reach the brain. The DNA damage observed in the cerebral cortex of rats given gold nanoparticles suggests that brain penetration is not merely theoretical.¹⁶

Pregnancy and Fetal Exposure

Animal studies raise some flags about gold nanoparticles during pregnancy. When pregnant rats were given radiolabeled gold nanoparticles, all three tested sizes (1.4, 18, and 80 nm) were detected in the placenta and amniotic fluid. The smallest, 1.4 nm particles, were found in placental tissue at concentrations two orders of magnitude higher than the larger particles. Crucially, the two smaller sizes were also detected in the fetuses themselves, while the 80 nm particles were not.²³

In mice, the timing of exposure matters. Prior to about mid-gestation (embryonic day 11.5 in mice), gold nanoparticles of 13 nm with various surface coatings were detected in fetal tissues in significant amounts. After that developmental milestone, fetal accumulation dropped dramatically, suggesting the maturing placenta becomes a more effective barrier.²⁴ A more recent mouse study found that while fetal skeletons looked normal under standard microscopy, advanced laser-based analysis revealed dose-dependent disruptions in bone mineralization, including altered calcium and magnesium levels and changes in developing bone structure.²⁵ These subtle skeletal effects were only visible with sensitive analytical tools, raising the question of what other effects might go undetected with conventional examination alone.

Effects on the Gut Microbiome

Most people taking colloidal gold supplements are swallowing it, which means the gut is the first biological system the particles encounter. Two mouse studies paint contrasting pictures, likely reflecting the complexity of the gut ecosystem. One study found that orally administered gold nanoparticles decreased microbial diversity in the gut, shifted the balance of major bacterial groups, and reduced populations of beneficial bacteria including Lactobacillus and certain species that produce short-chain fatty acids.²⁶ That same study, paradoxically, also found that the gold nanoparticles protected against experimentally induced colon inflammation.

A different study, focusing on osteoarthritis in mice, found that gold nanoparticles shifted gut microbial composition in a way that increased the abundance of Akkermansia and Lactobacillus, both generally considered beneficial.²⁷ These seemingly contradictory results probably reflect differences in particle size, surface coating, dose, and the disease model being studied. The honest summary is that gold nanoparticles do something to the gut microbiome, but whether that something is helpful, harmful, or both at once remains unclear.

Colloidal Gold Supplements and the Regulatory Landscape

Colloidal gold has become a common ingredient in dietary supplements marketed for cognitive enhancement, joint health, and general well-being. A recent laboratory analysis of commercially available colloidal gold supplements in the EU found that by the current regulatory definition, these products qualified as nanomaterials based on their particle size distributions. When researchers tested the supplements on human cells, they found no pronounced acute toxicity or antitumor effects on intestinal cells. However, kidney-derived cells (HEK293) showed increased toxicity when exposed to the actual supplement formulation compared to standard lab-prepared gold nanoparticles of similar size, suggesting that other ingredients in the supplement or the way it was formulated may matter for safety.²⁸

This is an important point that most supplement marketing glosses over. The toxicity profile of gold nanoparticles prepared under controlled laboratory conditions, with precise sizes and well-characterized coatings, does not automatically apply to whatever is in a bottle on a store shelf. Manufacturing consistency, the presence of additives, and the actual particle size distribution all affect biological behavior, and supplement manufacturers are generally not held to pharmaceutical-grade standards of characterization.

The Legacy of Medical Gold and Chrysiasis

Gold compounds have a long history in medicine, most famously as treatments for rheumatoid arthritis. Injectable gold salts like sodium aurothiomalate and oral gold preparations like auranofin showed genuine anti-inflammatory effects, but their widespread clinical use was ultimately limited by systemic toxicity and poor control over where the gold went in the body.²⁹ Up to about 30 percent of patients treated with gold compounds developed adverse immune reactions.³⁰

One of the more striking side effects of gold therapy was chrysiasis, a permanent blue-gray discoloration of the skin caused by gold deposits. It occurred after prolonged parenteral (injected) gold treatment, and ultraviolet light exposure accelerated the pigmentation. Electron microscopy and x-ray analysis confirmed the presence of metallic gold particles within the skin tissue itself.³¹ Chrysiasis was rare and associated with the ionic gold compounds used in injections rather than with nanoparticulate colloidal gold taken orally. But it serves as a reminder that gold, once deposited in tissues, can stay there essentially forever, and that the body does not treat it as an inert decoration passing harmlessly through.

Modern nanotechnology has revived interest in gold for medicine through atomically precise gold nanoclusters, typically under 3 nm, which show improved biocompatibility and more efficient renal clearance compared to the older drug formulations.²⁹ The field has learned from the problems of earlier gold drugs, but the supplements being sold today do not necessarily incorporate those lessons. There is a gap between cutting-edge gold nanocluster research and the colloidal gold suspensions available online, and it is a gap the consumer is usually left to bridge on their own.

Environmental Persistence of Gold Nanoparticles

As gold nanoparticles find wider use in medicine, electronics, cosmetics, and consumer products, their environmental fate is getting more attention. In freshwater bivalves (a type of clam used as a biological indicator), gold nanoparticles were taken up from both water and food at rates substantially higher than ionic gold. The organisms’ genes related to oxidative stress, immune defense, and programmed cell death all showed strong activation during nanoparticle exposure.¹⁹ One key difference between lab settings and the natural environment is that gold nanoparticles tend to clump together (aggregate) in natural water, which changes their effective size and potentially their toxicity. Aquatic species-sensitivity analysis found that nanoparticulate gold followed an aggregation-driven response rather than a straightforward dose-dependent pattern, unlike ionic gold, which behaved more predictably.¹⁸ This means environmental risk models built for dissolved metals may not accurately predict what gold nanoparticles do once they enter waterways, a wrinkle that regulators are still working through.